Literature DB >> 2895485

Production of climbing behaviour in mice requires both D1 and D2 receptor activation.

N A Moore1, M S Axton.   

Abstract

The ability of SKF38393 (a D1 agonist), quinpirole (a D2 agonist), and apomorphine (a mixed D1/D2 agonist) to induce stereotyped climbing behaviour in mice was investigated. Apomorphine produced a dose-related increase in stereotyped cage climbing which lasted for up to 60 min. SKF38393 and quinpirole failed to produce climbing when administered alone. When given in combination intense apomorphine-like cage climbing was observed which lasted for up to 2 h. Apomorphine or the combination of SKF38393 and quinpirole also produced biting of the cage. The climbing behaviour produced by either apomorphine or SKF38393/quinpirole combinations was antagonised by either the D1 antagonist, SCH23390 or the D2 antagonist clebopride. These results demonstrate that both D1 and D2 receptor activation is necessary to produce apomorphine-like cage climbing in mice.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895485     DOI: 10.1007/bf00176857

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.

Authors:  B Costall; R J Naylor; V Nohria
Journal:  Eur J Pharmacol       Date:  1978-07-01       Impact factor: 4.432

2.  Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.

Authors:  J Arnt; J Hyttel; J Perregaard
Journal:  Eur J Pharmacol       Date:  1987-01-13       Impact factor: 4.432

3.  Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.

Authors:  A R Braun; T N Chase
Journal:  Eur J Pharmacol       Date:  1986-11-19       Impact factor: 4.432

4.  Differential behavioral and biochemical effects of four dopaminergic agonists.

Authors:  G Gianutsos; K E Moore
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

5.  Effects of three dopamine agonists on cage climbing behavior.

Authors:  G Gianutsos; J L Palmeri
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

Authors:  L C Iorio; A Barnett; F H Leitz; V P Houser; C A Korduba
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

7.  Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions.

Authors:  P Barone; T A Davis; A R Braun; T N Chase
Journal:  Eur J Pharmacol       Date:  1986-04-09       Impact factor: 4.432

  7 in total
  12 in total

1.  Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors.

Authors:  D Eilam; H Talangbayan; G Canaran; H Szechtman
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Behavioural effects of the methanolic root bark extract of Securinega virosa in rodents.

Authors:  M G Magaji; J A Anuka; I Abdu-Aguye; A H Yaro; I M Hussaini
Journal:  Afr J Tradit Complement Altern Med       Date:  2008-01-22

3.  Effects of dopamine receptor antagonists on sucrose consumption and preference.

Authors:  R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Evaluation of the antipsychotic potential of aqueous fraction of Securinega virosa root bark extract in mice.

Authors:  M G Magaji; M Mohammed; R A Magaji; A M Musa; I Abdu-Aguye; I M Hussaini
Journal:  Metab Brain Dis       Date:  2014-01-22       Impact factor: 3.584

5.  Neurobehavioural evaluation of resveratrol in murine models of anxiety and schizophrenia.

Authors:  Mohammed Garba Magaji; Loretta Oghenekome Iniaghe; Mutiat Abolarin; Opeyemi Isa Abdullahi; Rabiu Abdusalam Magaji
Journal:  Metab Brain Dis       Date:  2016-11-22       Impact factor: 3.584

6.  Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists.

Authors:  J L Nunes; N A Sharif; A D Michel; R L Whiting
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

7.  Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.

Authors:  M R Zarrindast; K Shahed-Dirin
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Verticalization of behavior elicited by dopaminergic mobilization is qualitatively different between C57BL/6J and DBA/2J mice.

Authors:  E Tirelli; J M Witkin
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

9.  Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.

Authors:  A Davis; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  The ethyl acetate fraction of a methanolic extract of unripe noni (Morinda citrifolia Linn.) fruit exhibits a biphasic effect on the dopaminergic system in mice.

Authors:  Vijayapandi Pandy; Megala Narasingam; Kamini Vijeepallam; Syam Mohan; Vasudevan Mani; Zahurin Mohamed
Journal:  Exp Anim       Date:  2017-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.